期刊文献+

上调miR-101对肝细胞癌生物学行为的影响 被引量:4

Impact of upregulating miR-101 on biological behavior of hepatocellular carcinoma
原文传递
导出
摘要 目的:探讨mi R-101在肝细胞癌(HCC)细胞生物学行为的影响。方法:分别将mi R-101模拟物或mi RNA阴性对照序列转染Hep G2和SMMC-7721两种HCC细胞,以无处理自然生长的两种细胞为各自空白对照,观察mi R-101对两种细胞增殖、集落形成能力、凋亡及周期的影响,以及对侵袭和迁移能力的影响。结果:与各自的空白对照细胞比较,转染mi R-101模拟物后的Hep G2和SMMC-7721细胞的增值能力明显降低、细胞集落的形成明显减少、G0/G1期的细胞比例升高、细胞凋亡率明显增加、迁移与侵袭细胞数明显减少(均P<0.05);转染mi RNA阴性对照序列对两种细胞的以上指标无明显影响(均P>0.05)。结论:mi R-101可能在HCC细胞中起到了抑癌基因的作用,上调其表达能抑制HCC的恶性生物学行为。 Objective: To investigate the influence ofmiR-101 on the biological behavior ofhepatocellular carcinoma (HCC) cells. Methods: The HCC HepG2 and SMMC-7721 cells were transfected with miR-101 mimics or miRNA negative control sequences, using the two types of cells cultured without any treatment as corresponding blank control, and then the effect of miR-101 on proliferation, colony formation ability, apoptosis and cell cycle, as well as the migration and invasion ability of the two types of cells were observed. Results: Compared with corresponding blank control, in either HepG2 or SMMC-7721 cells after transfection with miR-101 minics, the proliferative ability was decreased, colony formation was reduced, G0/G1 phase cell ratio was increased, apoptosis rate was increased, and the ability of migration and invasion was reduced markedly (all P〈0.05); transfection of miRNA negative control sequences exerted no obvious effect on above parameters for the two types of cells (all P〉0.05). Conclusion: miR-101 possibly plays a role as cancer suppressor gene in HCC cells, and upregulating its expression may suppress the malignant activity of HCC.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2015年第7期963-969,共7页 China Journal of General Surgery
关键词 肝细胞 微RNAS 肿瘤侵润 Carcinoma, Hepatocellular MicroRNAs Neoplasm Invasiveness
  • 相关文献

参考文献25

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
  • 2Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917.
  • 3Shariff MI, Cox IJ, Gomaa AI, et al. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics[J]. Expert Rev Gastroenterol Hepatol, 2009, 3(4):353-367.
  • 4Venook AP, Papandreou C, Furuse J, et al. The incidence and epidemiology of hepatoeellular carcinoma: a global and regional perspective[J]. Oneologist, 2010, 15(Suppl 4):5-13.
  • 5Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences[J]. N Engl J Med, 2004, 350(11): 1118-1129.
  • 6Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment[J]. Environ Health Perspect, 2010, 118(6):818-824.
  • 7Bartel DE MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2):281-297.
  • 8Rigoutsos I. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites[J]. Cancer Res, 2009, 69(8):3245-3248.
  • 9He XP, Shao Y, Li XL, et al. Downregutation of miR-101 in gastric cancer correlates with cyelooxygenase-2 overexpression and tumor growth[J]. FEBS J, 2012, 279(22):4201-4212.
  • 10Wang R, Wang HB, Hao CJ, et al. MiR-101 is involved in human breast carcinogenesis by targeting Stathminl [J]. PLoS One, 2012, 7(10):e46173. doi: 10.1371/journal.pone.0046173.

同被引文献26

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部